Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Commentary
Page 11
Recently published articles about
Commentary
JCP
Commentary
Psychiatry's Niche Role in the COVID-19 Pandemic
April 7, 2020
During the COVID-19 pandemic, psychiatrists may respond to the "all hands on deck" call from health care institutions. This commentary looks at how expertise in distinguishing and managing normal...
Joseph F. Goldberg
JCP
Commentary
Repurposing Psychiatry During COVID-19
April 7, 2020
This commentary considers the ways in which resources related to psychiatry, including digital tools, clinical skills, and psychiatric medications, can be put to effective use in the context of...
Ginger E. Nicol
,
Jordan F. Karp
,
Angela M. Reiersen
, et al
JCP
Commentary
A Viewpoint From Paris on COVID-19
March 31, 2020
In this commentary, Dr Corruble gives an account from the front lines of treating psychiatric patients during the COVID-19 outbreak in Paris, France.
Emmanuelle Corruble
JCP
Commentary
COVID-19 Diary From a Psychiatry Department in Italy
March 31, 2020
In this commentary, the authors describe the hospital environment and the protective measures being taken during the COVID-19 pandemic in a hospital in Tuscany, Italy.
Andrea Fagiolini
,
Alessandro Cuomo
,
Ellen Frank
JCP
Commentary
Increasing Schizophrenia Placebo Responses
March 3, 2020
Read commentary on the possible reasons why placebo response rates in clinical trials for schizophrenia are increasing.
Thomas P. Laughren, MD
JCP
Commentary
Commentary
December 3, 2019
This commentary discusses the findings and implications of a recent post hoc study by Thase and colleagues on the utility of combinatorial pharmacogenomics in depression.
Joseph F. Goldberg
«
1
…
9
10
11
12
13
…
27
»
